| |
|

October 2014 Vol. 2 No. 10
Other viewing option
Abstract
• Full
text
•Reprint
(PDF) (278 KB)
Search Pubmed for articles by:
Thanh
TB
Huong
DTL
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 2(10) pp. 216-224,
October, 2014
Copyright © 2014 Merit Research Journals |
|
Original Research Article
Curcuma longa extract suppresses
inflammation in mice with DSS-induced acute colitis |
|
| |
| |
|
Tung Bui Thanh*, Hai Nguyen Thanh, Huong Le-Thi-Thu and
Huong Duong Thi Ly
|
|
|
School of Medicine and Pharmacy,
Vietnam National University, Hanoi, 144 Xuan Thuy, Cau Giay, Ha
Noi, Vietnam
*Corresponding
Author's E-mail:
tungasia82@yahoo.es; Tel: +84-4-85876172; Fax:
+84-0437450188
Accepted October 23, 2014 |
|
|
Abstract |
|
|
The etiology and
pathophysiology of inflammatory bowel disease (IBD), which is a
multifactorial disorder, remain poorly understood. Curcuma
longa extract has been demonstrated to exhibit
anti-inflammatory activity in the literature. Here, we examined
the effect of C. longa extract on dextran sulfate sodium
(DSS)-induced colitis over a period of 7 days. The extract (150
mg/kg/b.w.) was mixed with the diet of the mice. C. longa
significantly reduced the Disease Activity Index and
myeloperoxidase activity. The extract also suppressed the levels
of pro-inflammatory IL-1β, IL-6, IL-17, INF-γ, TNF-α and
increased the level of IL-10. Additionally, the protein
expression levels of COX-2 and iNOS were reduced by C. longa
extract. Our results suggest that C. longa extract exerts
beneficial effects on experimental colitis; therefore, we
propose that this extract may have therapeutic implications for
ulcerative colitis.
Keywords: Curcuma longa extract, Colitis, DSS,
Inflammation, Mice
|
|
|
|